Invasive growth associated with cold-inducible RNA-binding protein expression drives recurrence of surgically resected brain metastases. Issue 9 (12th January 2021)

• Record Type: Journal Article
• Authors: Dankner, Matthew; Caron, Maxime; Al-Saadi, Tariq; Yu, WenQing; Ouellet, Véronique; Ezzeddine, Rima; Maritan, Sarah M; Annis, Matthew G; Le, Phuong Uyen; Nadaf, Javad; Neubarth, Noah S; Savage, Paul; Zuo, Dongmei; Couturier, Charles P; Monlong, Jean; Djambazian, Haig; Altoukhi, Huda; Bourque, Guillaume; Ragoussis, Jiannis; Diaz, Roberto J; Park, Morag; Guiot, Marie-Christine; Lam, Stephanie; Petrecca, Kevin; Siegel, Peter M
• Is Part Of: Neuro-oncology. Volume 23:Issue 9(2021)
• Page Start: 1470
• Page End: 1480
• Publication Date: 2021-01-12
• Subjects: brain metastasis -- leptomeningeal -- recurrence -- scRNAseq -- stereotactic radiosurgery; Brain Neoplasms -- Periodicals; Brain -- Tumors -- Periodicals; Brain -- Cancer -- Periodicals; Nervous system -- Cancer -- Periodicals; 616.99481
• DOI: 10.1093/neuonc/noab002
• Languages: English
• ISSNs: 1522-8517

Abstract

Abstract: Background: Sixty percent of surgically resected brain metastases (BrM) recur within 1 year. These recurrences have long been thought to result from the dispersion of cancer cells during surgery. We tested the alternative hypothesis that invasion of cancer cells into the adjacent brain plays a significant role in local recurrence and shortened overall survival. Methods: We determined the invasion pattern of 164 surgically resected BrM and correlated with local recurrence and overall survival. We performed single-cell RNA sequencing (scRNAseq) of >15, 000 cells from BrM and adjacent brain tissue. Validation of targets was performed with a novel cohort of BrM patient-derived xenografts (PDX) and patient tissues. Results: We demonstrate that invasion of metastatic cancer cells into the adjacent brain is associated with local recurrence and shortened overall survival. scRNAseq of paired tumor and adjacent brain samples confirmed the existence of invasive cancer cells in the tumor-adjacent brain. Analysis of these cells identified cold-inducible RNA-binding protein (CIRBP) overexpression in invasive cancer cells compared to cancer cells located within the metastases. Applying PDX models that recapitulate the invasion pattern observed in patients, we show that CIRBP is overexpressed in highly invasive BrM and is required for efficient invasive growth in the brain. Conclusions: These data demonstrate peritumoral invasion as a driver of treatment failure in BrM that is functionally mediated by CIRBP. These findings improve our understanding of the biology underlying postoperative treatment failure and lay the groundwork for rational clinical trial development based upon invasion pattern in surgically resected BrM.